12.38
0.27 (2.23%)
| Previous Close | 12.11 |
| Open | 12.19 |
| Volume | 523,938 |
| Avg. Volume (3M) | 476,551 |
| Market Cap | 572,500,736 |
| Price / Sales | 0.750 |
| Price / Book | 0.680 |
| 52 Weeks Range | |
| Earnings Date | 29 Jul 2025 - 4 Aug 2025 |
| Profit Margin | -55.80% |
| Operating Margin (TTM) | 6.15% |
| Diluted EPS (TTM) | -8.27 |
| Quarterly Revenue Growth (YOY) | 0.80% |
| Total Debt/Equity (MRQ) | 16.79% |
| Current Ratio (MRQ) | 2.57 |
| Operating Cash Flow (TTM) | 134.40 M |
| Levered Free Cash Flow (TTM) | 131.31 M |
| Return on Assets (TTM) | 2.26% |
| Return on Equity (TTM) | -36.78% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Avanos Medical, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | -0.67 |
|
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 3.80% |
| % Held by Institutions | 96.13% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 15 Sep 2025 | Announcement | Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care |
| 05 Aug 2025 | Announcement | Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors |
| 05 Aug 2025 | Announcement | Avanos Medical, Inc. Announces Second Quarter 2025 Results |
| 31 Jul 2025 | Announcement | Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical |
| 24 Jul 2025 | Announcement | Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |